BYAH logo

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH), 0 değerindeki bir Consumer Cyclical şirketidir. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 50/100 puan alıyor.

Son analiz: 17 Mar 2026
50/100 AI Puanı

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Tüketici İşletmesi Genel Bakışı

CEOXiaoqiu Zhang
Çalışanlar31
MerkezWuxi, CN
Halka Arz Yılı2025

Park Ha Biological Technology Co., Ltd. is a China-based investment holding company specializing in the development and distribution of skincare products under the “Park Ha” brand. The company operates in the competitive personal care market, utilizing direct sales and franchise models within the People's Republic of China.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 17 Mar 2026

Yatırım Tezi

Park Ha Biological Technology Co., Ltd. operates in the attractive Chinese skincare market, evidenced by a high gross margin of 90.6%. However, the company's negative profit margin of -965.0% raises concerns about operational efficiency and cost management. With a market capitalization of $0.00B and a negative P/E ratio of -0.03, the company's valuation is challenging. Growth catalysts include expanding its franchise network and enhancing its direct sales capabilities. Key risks include intense competition in the skincare market and the company's current lack of profitability. Monitoring the company's ability to improve its bottom line and effectively manage its operational costs is crucial for assessing its long-term viability.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Gross Margin of 90.6% indicates strong pricing power and efficient cost of goods sold.
  • Negative Profit Margin of -965.0% signals significant operational inefficiencies or high operating expenses.
  • Market Cap of $0.00B reflects the company's small size and potential illiquidity.
  • P/E Ratio of -0.03 indicates the company is currently not profitable.
  • Beta of -3.94 suggests the stock is significantly less volatile than the market, but may also reflect a lack of trading activity.

Rakipler & Benzerleri

Güçlü Yönler

  • Established brand presence in the Chinese skincare market.
  • Franchise network provides a scalable distribution model.
  • High gross margin indicates strong pricing power.
  • Focus on a specific niche within the consumer cyclical sector.

Zayıflıklar

  • Negative profit margin indicates operational inefficiencies.
  • Small market capitalization limits access to capital.
  • Limited geographic diversification, relying solely on the Chinese market.
  • High beta suggests potential volatility.

Katalizörler

  • Upcoming: Expansion of the franchise network into new regions within China, targeting Tier 2 and Tier 3 cities by Q4 2026.
  • Ongoing: Development and launch of new skincare products catering to specific consumer needs and preferences, with a focus on natural and organic ingredients.
  • Ongoing: Implementation of targeted marketing campaigns and social media strategies to enhance brand awareness and drive customer acquisition.

Riskler

  • Potential: Intense competition from established domestic and international brands, potentially impacting market share and profitability.
  • Potential: Changes in consumer preferences and trends in the skincare market, requiring continuous innovation and adaptation.
  • Ongoing: Regulatory changes and compliance requirements in China, potentially increasing operational costs and complexity.
  • Potential: Economic downturns affecting consumer spending on discretionary items, potentially reducing demand for skincare products.

Büyüme Fırsatları

  • Expanding Franchise Network: Park Ha can grow by expanding its franchise network across China, particularly in Tier 2 and Tier 3 cities where demand for skincare products is increasing. The market size for skincare products in these regions is estimated to reach $50 billion by 2028. By offering attractive franchise terms and providing comprehensive support to franchisees, Park Ha can accelerate its market penetration and increase brand visibility. This expansion can be achieved within the next 3-5 years.
  • Enhancing Direct Sales Capabilities: Investing in its direct sales channels, including online platforms and direct marketing initiatives, can enable Park Ha to reach a broader customer base and improve customer engagement. The e-commerce market for skincare products in China is projected to grow to $80 billion by 2027. By leveraging data analytics and personalized marketing, Park Ha can optimize its direct sales efforts and drive revenue growth. This initiative can be implemented within the next 2 years.
  • Product Innovation and Diversification: Developing new and innovative skincare products that cater to specific consumer needs and preferences can help Park Ha differentiate itself from competitors and capture a larger market share. The demand for specialized skincare products, such as anti-aging and acne treatment solutions, is growing rapidly. By investing in research and development and collaborating with leading dermatologists, Park Ha can launch new products that address unmet consumer needs. This can be an ongoing effort with new products released every 12-18 months.
  • Strengthening Brand Awareness: Implementing targeted marketing campaigns and leveraging social media platforms to enhance brand awareness and build brand loyalty can drive customer acquisition and retention. The use of Key Opinion Leaders (KOLs) and influencers in the beauty industry is highly effective in China. By partnering with popular KOLs and creating engaging content, Park Ha can increase its brand visibility and attract new customers. This is an ongoing opportunity with continuous marketing efforts.
  • Strategic Partnerships and Collaborations: Forming strategic partnerships with complementary businesses, such as beauty salons and spas, can expand Park Ha's distribution channels and reach new customer segments. Collaborating with these businesses can provide Park Ha with access to a wider customer base and enhance its brand image. This initiative can be pursued within the next 1-3 years, focusing on building mutually beneficial relationships.

Fırsatlar

  • Expanding the franchise network to new regions within China.
  • Developing new and innovative skincare products.
  • Leveraging e-commerce and social media to enhance direct sales.
  • Forming strategic partnerships with complementary businesses.

Tehditler

  • Intense competition from established domestic and international brands.
  • Changing consumer preferences and trends in the skincare market.
  • Regulatory changes and compliance requirements in China.
  • Economic downturns affecting consumer spending on discretionary items.

Rekabet Avantajları

  • Brand Recognition: The “Park Ha” brand may have some level of recognition within the Chinese market, providing a competitive edge.
  • Franchise Network: The established franchise network provides a distribution advantage and recurring revenue stream.
  • Proprietary Formulations: The company's skincare products may contain unique formulations that differentiate them from competitors.

BYAH Hakkında

Park Ha Biological Technology Co., Ltd. is an investment holding company that operates in the consumer cyclical sector, specifically within the personal products and services industry. The company focuses on the development, distribution, and sales of skincare products under its proprietary “Park Ha” brand. Headquartered in Wuxi, China, Park Ha conducts its business through subsidiaries that engage in direct product sales and franchise operations. The company's business model emphasizes a direct-to-consumer approach, leveraging franchise networks to expand its market reach across the People's Republic of China. Park Ha aims to cater to the growing demand for skincare products in the Chinese market by offering a range of products designed to meet diverse consumer needs. While the company's history and specific founding details are not provided, its current strategy revolves around strengthening its brand presence and optimizing its distribution channels to enhance profitability and market share in the competitive skincare industry. The company currently employs 31 individuals.

Ne Yaparlar

  • Develops skincare products under the “Park Ha” brand.
  • Operates as an investment holding company.
  • Engages in direct product sales through its subsidiaries.
  • Provides franchise services to expand its distribution network.
  • Focuses on the Chinese skincare market.
  • Manages a portfolio of skincare products targeting various consumer needs.

İş Modeli

  • Develops and markets skincare products under its own brand.
  • Generates revenue through direct sales of products to consumers.
  • Expands market reach through a franchise model, earning fees and royalties from franchisees.

Sektör Bağlamı

The personal products and services industry is characterized by intense competition, evolving consumer preferences, and a constant need for innovation. The Chinese skincare market, in particular, is experiencing substantial growth, driven by increasing disposable incomes and a rising awareness of skincare products. Park Ha Biological Technology Co., Ltd. operates in this dynamic environment, competing with both domestic and international brands. Key trends include the growing popularity of e-commerce, the demand for natural and organic products, and the increasing influence of social media marketing. Companies like AZI, BTBD, CENN, CGTL, and DSS represent some of the competitors in this space, each vying for market share through different product offerings and distribution strategies.

Kilit Müşteriler

  • Consumers in the People's Republic of China seeking skincare products.
  • Franchisees who operate Park Ha branded stores and sell products.
  • Customers seeking a range of skincare solutions for different skin types and concerns.
AI Güveni: 69% Güncellendi: 17 Mar 2026

Finansallar

Grafik & Bilgi

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

BYAH için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

BYAH için Wall Street fiyat hedefi analizi.

MoonshotScore

50/100

Bu puan ne anlama geliyor?

MoonshotScore, BYAH'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Xiaoqiu Zhang

CEO

Xiaoqiu Zhang serves as the CEO of Park Ha Biological Technology Co., Ltd., overseeing the company's operations and strategic direction. While specific details regarding Zhang's educational background and previous roles are not available, their leadership is focused on driving growth and profitability within the competitive skincare market in China. Zhang is responsible for managing the company's 31 employees and ensuring the effective execution of its business strategy.

Sicil: As CEO, Xiaoqiu Zhang is responsible for guiding Park Ha Biological Technology Co., Ltd. through the challenges and opportunities of the Chinese skincare market. Specific achievements and milestones under Zhang's leadership are not detailed in the provided information. However, their focus is likely on expanding the company's franchise network, enhancing its direct sales capabilities, and improving its overall financial performance.

BYAH Hakkında Sıkça Sorulan Sorular

BYAH için değerlendirilmesi gereken temel faktörler nelerdir?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) şu anda yapay zeka skoru 50/100, orta puanı gösteriyor. Temel güçlü yan: Established brand presence in the Chinese skincare market.. İzlenmesi gereken birincil risk: Potential: Intense competition from established domestic and international brands, potentially impacting market share and profitability.. Bu bir finansal tavsiye değildir.

BYAH MoonshotScore'u nedir?

BYAH şu anda MoonshotScore'da 50/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

BYAH verileri ne sıklıkla güncellenir?

BYAH fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler BYAH hakkında ne diyor?

BYAH için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

BYAH'a yatırım yapmanın riskleri nelerdir?

BYAH için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from established domestic and international brands, potentially impacting market share and profitability.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

BYAH'ın P/E oranı nedir?

BYAH için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için BYAH'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

BYAH aşırı değerli mi, yoksa düşük değerli mi?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

BYAH'ın temettü verimi nedir?

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is limited, and the absence of analyst coverage introduces uncertainty.
  • The company's future performance is subject to various risks and uncertainties, including competition, regulatory changes, and economic conditions.
Veri Kaynakları

Popüler Hisseler